Injected intratumorally, this compound decreased tumor mass and increased the survival of GL261 glioma-bearing mice, underscoring the involvement of EAAT1 in Glu trafficking in gliomas, and further confirming that this transporter supports glioma cell proliferation [38]. The gene discussed is SLC1A3; the disease is central nervous system cancer.